医院体外膜氧合能力与儿童心脏骤停生存相关
该研究利用2016–2018年HCUP NIS数据,识别0–18岁儿童心脏骤停住院(含院内外),共1276例,主要终点为院内生存。队列总生存率44%,ECMO能力医院50%、非ECMO医院32%;校正患者及医院因素后,ECMO能力医院与更高院内生存相关(OR 1.49,95%CI 1.09–2.02)。ECMO能力医院患者更年轻(中位3岁 vs 11岁,p<0.001)且更常见复杂慢性病(尤其先天性心脏病),10.9%(88/811)接受ECMO支持。作者认为需未来研究理解照护差异及其他组织因素以改善结局。
要点
- 儿童心脏骤停住院总生存率44%,ECMO能力医院50% vs 非ECMO医院32%。
- 校正患者及医院因素后,ECMO能力医院与更高院内生存相关(OR 1.49,95%CI 1.09–2.02)。
- ECMO能力医院患者更年轻(中位3岁 vs 11岁,p<0.001)且更常见复杂慢性病,尤其先天性心脏病。
- ECMO能力医院中10.9%(88/811)的患者接受了ECMO支持。
- 作者认为需未来研究理解照护差异及其他组织因素以改善儿童心脏骤停结局。
适用人群与场景
- 0–18岁儿童心脏骤停住院患者,包括院内心脏骤停和院外心脏骤停后入院。
研究设计与关键结果
- 研究类型:基于美国HCUP NIS 2016–2018年数据的分析,共识别1276例儿童心脏骤停住院。
- 主要终点:院内生存;队列总生存率44%,ECMO能力医院50% vs 非ECMO医院32%。
- 校正患者层面及医院因素后,ECMO能力医院与更高院内生存相关(OR 1.49,95%CI 1.09–2.02)。
- ECMO能力医院患者更年轻(中位3岁 vs 11岁,p<0.001),更常见复杂慢性病,尤其先天性心脏病。
- ECMO能力医院中10.9%(88/811)的患者接受了ECMO支持。
证据类型、等级与局限
- 证据类型:基于大型美国行政数据集的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来需开展工作以理解照护提供差异及儿童心脏骤停的其他组织因素,从而改善结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Extracorporeal membrane oxygenation (ECMO) provides temporary support in severe cardiac or respiratory failure and can be deployed in children who suffer cardiac arrest. However, it is unknown if a hospital's ECMO capability is associated with better outcomes in cardiac arrest. We evaluated the association between pediatric cardiac arrest survival and the availability of pediatric extracorporeal membrane oxygenation (ECMO) at the treating hospital.
METHODS: We identified cardiac arrest hospitalizations, including in- and out-of-hospital, in children (0-18 years old) using data from the Health Care Utilization Project (HCUP) National Inpatient Sample (NIS) between 2016 and 2018. The primary outcome was in-hospital survival. Hierarchical logistic regression models were built to test the association between hospital ECMO capability and in-hospital survival.
RESULTS: We identified 1276 cardiac arrest hospitalizations. Survival of the cohort was 44%; 50% at ECMO-capable hospitals and 32% at non-ECMO hospitals. After adjusting for patient-level factors and hospital factors, receipt of care at an ECMO- capable hospital was associated with higher in-hospital survival, with an odds ratio of 1.49 [95% CI 1.09, 2.02]. Patients who received treatment at ECMO-capable hospitals were younger (median 3 years vs 11 years, p < 0.001) and more likely to have a complex chronic condition, specifically congenital heart disease. A total of 10.9% (88/811) of patients at ECMO-capable hospitals received ECMO support.
CONCLUSION: A hospital's ECMO capability was associated with higher in-hospital survival among children suffering cardiac arrest in this analysis of a large United States administrative dataset. Future work to understand care delivery differences and other organizational factors in pediatric cardiac arrest is necessary to improve outcomes.
参考来源
- Pollack BE, Barbaro RP, Gorga SM, et al. Hospital ECMO capability is associated with survival in pediatric cardiac arrest. Resuscitation. 2023. PMID: 37245647. doi:10.1016/j.resuscitation.2023.109853
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。